Written by: Tammy McClellan, PharmD
Download Here

The purpose of this PQI is to expand on therapy management of ibrutinib (Imbruvica) when used in combination with obinutuzumab (Gazyva).

Continue reading Ibrutinib expansion with Obinutuzumab

Read More